PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Total Assets (Quarterly) : 46.75M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 46.75M |
| January 31, 2026 | 55.87M |
| October 31, 2025 | 55.98M |
| July 31, 2025 | 45.11M |
| April 30, 2025 | 55.17M |
| January 31, 2025 | 43.83M |
| October 31, 2024 | 55.10M |
| July 31, 2024 | 70.19M |
| April 30, 2024 | 59.90M |
| January 31, 2024 | 71.36M |
| October 31, 2023 | 78.88M |
| July 31, 2023 | 79.88M |
| April 30, 2023 | 73.28M |
| January 31, 2023 | 77.95M |
| October 31, 2022 | 82.35M |
| July 31, 2022 | 87.39M |
| April 30, 2022 | 90.62M |
| January 31, 2022 | 91.94M |
| October 31, 2021 | 92.31M |
| July 31, 2021 | 6.637M |
| April 30, 2021 | 7.404M |
| January 31, 2021 | 8.262M |
| October 31, 2020 | 8.941M |
| July 31, 2020 | 7.432M |
| April 30, 2020 | 6.167M |
| Date | Value |
|---|---|
| January 31, 2020 | 5.338M |
| October 31, 2019 | 5.338M |
| July 31, 2019 | 5.606M |
| April 30, 2019 | 5.782M |
| January 31, 2019 | 5.837M |
| October 31, 2018 | 6.067M |
| July 31, 2018 | 7.081M |
| April 30, 2018 | 6.413M |
| January 31, 2018 | 6.725M |
| October 31, 2017 | 7.915M |
| July 31, 2017 | 9.525M |
| April 30, 2017 | 8.668M |
| January 31, 2017 | 7.615M |
| October 31, 2016 | 6.732M |
| July 31, 2016 | 7.524M |
| April 30, 2016 | 7.160M |
| January 31, 2016 | 8.002M |
| October 31, 2015 | 7.978M |
| July 31, 2015 | 8.985M |
| April 30, 2015 | 9.298M |
| January 31, 2015 | 6.626M |
| October 31, 2014 | 6.659M |
| July 31, 2014 | 8.198M |
| April 30, 2014 | 9.316M |
| January 31, 2014 | 5.712M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.77M |
| Shareholders Equity (Quarterly) | 34.56M |
| Current Ratio | 45.28 |